Pradeep M Sathe1, Jurgen Venitz
1U.S. Food and Drug Administration, Office of Generic Drugs, Division of Bioequivalence, Rockville, Maryland 20855, USA. sathe@cder.fda.gov
Artificial neural networks (NN) outperformed multiple linear regression (MLR) in predicting diltiazem dissolution profiles. NN demonstrated superior internal and external predictability for formulation variables influencing drug release.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: